Research

Hormonal

Acute or intermittent administration of the flavonoid fisetin acts as a senolytic to clear senescent cells, thereby reducing age-related pathology and extending both healthspan and lifespan in aged mice.

Fisetin is a potent senolytic that extends healthspan and lifespan in mice when administered intermittently at high doses (e.g., 100 mg/kg body weight for 5 days). While human trials are beginning, current evidence supports an intermittent 'hit-and-run' dosing strategy rather than daily supplementation to maximize efficacy and minimize potential side effects. Consult a physician before starting high-dose supplementation.

GoodSupportsHIGH confidence
Acute or intermittent treatment of progeroid and old mice with fisetin reduced senescence markers in multiple tissues... Administration of fisetin to wild-type mice late in life restored tissue homeostasis, reduced age-related pathology, and extended median and maximum lifespan.
Matthew J. Yousefzadeh et al. · EBioMedicine · 2018

Why this rating

Strong preclinical evidence in multiple mouse models (progeroid and wild-type) and human tissue explants, though human clinical trial data is not yet included in this paper.

Source

Fisetin is a senotherapeutic that extends health and lifespan

Matthew J. Yousefzadeh et al. · EBioMedicine · 2018

DOI 10.1016/j.ebiom.2018.09.015

mechanism_onlyCited 964×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →